Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/88593| Title: | Oral antithrombotic therapy and gastrointestinal bleeding : the good, the bad and the ugly |
| Authors: | Riva, Nicoletta Apostolakis, Stavros Lip, Gregory Y. H. |
| Keywords: | Anticoagulants (Medicine) Anticoagulants (Medicine) -- Administration Thrombosis Atrial fibrillation |
| Issue Date: | 2012 |
| Publisher: | Blackwell Publishing Ltd. |
| Citation: | Riva, N., Apostolakis, S., & Lip, G. Y. H. (2012). Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly. International Journal of Clinical Practice, 66(1), 2-4. |
| Abstract: | Patients with atrial fibrillation (AF) have a substantial risk of stroke and thromboembolism. This risk is strongly affected by comorbidities and demographical features and the risk ranges from being insignificant, in young individuals without cardiovascular disease, to more than 20% per year, in elderly patients with complex cardiovascular comorbidities (1). Antithrombotic therapy (specifically, oral anticoagulation) is effective in reducing the risk of stroke and systemic embolism related to AF, but carries an increased risk of major bleeding (2). |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/88593 |
| Appears in Collections: | Scholarly Works - FacM&SPat |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Oral antithrombotic therapy and gastrointestinal bleeding.pdf Restricted Access | 116.77 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.